Digital Health Technology Derived Biomarkers and Outcome Assessments for Remote Monitoring and Endpoint Development (UG3/UH3 - Clinical Trial Optional)
ID: 357087Type: Posted
Overview

Buyer

National Institutes of Health (HHS-NIH11)

Eligible Applicants

Others

Funding Category

Health

Funding Instrument

Cooperative Agreement

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/357087

Additional Information

http://grants.nih.gov/grants/guide/pa-files/PAR-25-170.html
Timeline
    Description

    The National Institutes of Health (NIH) has announced a funding opportunity titled "Digital Health Technology Derived Biomarkers and Outcome Assessments for Remote Monitoring and Endpoint Development," aimed at supporting the development and validation of digital health technology-driven biomarkers and clinical outcome assessments for use in clinical trials. This initiative seeks to enhance the standardization of remote assessments and address unmet clinical needs across multiple diseases, requiring applicants to engage with non-profit patient advocacy organizations and evaluate technologies in diverse populations. The funding mechanism consists of two phases: the UG3 phase focuses on assessing the technical performance of proposed technologies, while the UH3 phase supports longitudinal clinical studies for validation. Interested applicants can find more information and application details at the NIH grants website, with a submission deadline of June 22, 2026, and no cost-sharing or matching requirement.

    Point(s) of Contact
    grantsinfo@nih.gov
    Files
    Title
    Posted
    PAR-25-170-Full-Announcement.html
    PAR-25-170.html
    The Department of Health and Human Services, through the National Institutes of Health (NIH), has announced a funding opportunity titled "Digital Health Technology Derived Biomarkers and Outcome Assessments for Remote Monitoring and Endpoint Development". This initiative seeks to develop and validate digital health technology-driven biomarkers and clinical outcome assessments for remote monitoring in clinical trials. The program supports research across multiple diseases, emphasizing collaboration with individuals with lived experience and patient advocacy groups. The funding is built around a two-phase mechanism: the first phase (UG3) focuses on evaluating the technical performance of proposed digital health technologies, while the second phase (UH3) supports longitudinal clinical studies to validate the technologies. Key goals include enhancing the standardization of remote assessments and meeting unmet clinical needs in varied disease areas. Eligible applicants include various educational institutions, for-profit and non-profit organizations, and should adhere to specific application and submission protocols. Emphasizing community engagement and a clear strategic plan, the program mandates proper data management and sharing strategies. This funding opportunity aligns with NIH's commitment to advancing digital health initiatives for improved patient outcomes and clinical trial efficiency.
    Similar Opportunities
    Developing Digital Therapeutics for Substance Use Disorders (UG3/UH3 Clinical Trial optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Developing Digital Therapeutics for Substance Use Disorders (UG3/UH3 Clinical Trial optional)" aimed at advancing the development of Digital Therapeutics (DTx) for treating Substance Use Disorders (SUDs). This initiative seeks to support the creation of safe and effective clinical-grade digital platforms that can deliver therapeutic treatments, particularly for conditions that currently lack FDA-approved medications. The funding mechanism involves a two-phase cooperative agreement, with the UG3 phase focusing on initial milestones and design testing for up to two years, followed by the UH3 phase, which can extend for an additional three years upon successful completion of the UG3 phase. Eligible applicants include a diverse range of organizations, such as educational institutions, tribal governments, and community-based organizations. The application process opens on February 26, 2024, with multiple deadlines extending through late 2026. For further inquiries, interested parties can contact NIH Grants Information at grantsinfo@nih.gov.
    Advancing Research on the Application of Digital Health Technology to the Management of Type 2 Diabetes (R01- Clinical Trail Required)
    National Institutes of Health
    The National Institutes of Health (NIH) is inviting applications for the funding opportunity titled "Advancing Research on the Application of Digital Health Technology to the Management of Type 2 Diabetes (R01- Clinical Trial Required)." This initiative aims to explore the efficacy and clinical effectiveness of multimodality digital health technology approaches, such as continuous glucose monitoring and telemedicine, in the remote management of diabetes. The research is crucial for enhancing the understanding of diabetes management, prevention, diagnosis, and treatment, with a focus on improving health outcomes. The NIH anticipates awarding three grants for projects lasting up to five years, with application deadlines set for November 7, 2025, and October 6, 2026. For further inquiries, applicants can contact NIH Grants Information at grantsinfo@nih.gov or visit the detailed announcement at https://grants.nih.gov/grants/guide/rfa-files/RFA-DK-26-315.html.
    Translational Center for Accelerating the Use of Digital Health Technologies Data in AD/ADRD Research
    National Institutes of Health
    The National Institutes of Health (NIH) is announcing a forthcoming funding opportunity titled "Translational Center for Accelerating the Use of Digital Health Technologies Data in AD/ADRD Research." This initiative aims to establish a comprehensive center focused on developing infrastructure and best practices for the effective use of digital health technology data in Alzheimer's Disease (AD) and related dementias research. The center will create a cloud-based, federated data repository that adheres to the FAIR principles, facilitating the secure storage, processing, and integration of diverse data types generated from AD/ADRD studies. While applications are not currently being solicited, interested parties are encouraged to prepare collaborative proposals in anticipation of the official announcement, with an estimated synopsis posting date of February 27, 2026, and a projected award date of April 25, 2027. For further inquiries, potential applicants can contact Dr. Nadezda Radoja at nadezda.radoja@nih.gov or by phone at 240-447-1938.
    Laboratories to Optimize Digital Health (R01 Clinical Trial Required)
    National Institutes of Health
    The National Institutes of Health (NIH) is inviting applications for the "Laboratories to Optimize Digital Health" initiative, aimed at enhancing the reach and effectiveness of digital mental health interventions through innovative research projects. This funding opportunity focuses on developing digital health test beds to optimize existing evidence-based interventions, particularly targeting vulnerable populations and addressing health disparities. The initiative supports clinical trials and encourages collaboration between software developers and researchers to understand the mechanisms of action behind these interventions. Applications open on January 5, 2025, with multiple due dates leading to awards expected to begin in July 2025. For further inquiries, applicants can contact NIH Grants Information at grantsinfo@nih.gov, and additional details can be found at NIH Grants.
    Blueprint MedTech Translator (UG3/UH3 - Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity titled "Blueprint MedTech Translator (UG3/UH3 - Clinical Trial Optional)" aimed at supporting innovative research in the development of therapeutic and diagnostic devices for disorders affecting the nervous or neuromuscular systems. This cooperative agreement program encourages investigators to conduct translational activities and clinical feasibility studies, with a focus on advancing medical device technology through collaboration with NIH resources for design, testing, and regulatory support. The initiative is particularly significant as it seeks to accelerate the clinical introduction of medical technologies, ultimately improving patient outcomes while adhering to best practices in research and development. Interested applicants, including various eligible institutions and organizations, must submit their proposals by January 28, 2028, and can find more information at the NIH grants website or contact NIH Grants Information at grantsinfo@nih.gov.
    Notice of Intent to Publish a Funding Opportunity Announcement for Advancing Research on the Application of Digital Health Technology to the Management of Type 2 Diabetes
    National Institutes of Health
    The National Institutes of Health (NIH) intends to publish a Notice of Funding Opportunity (NOFO) aimed at advancing research on the application of digital health technology in managing Type 2 Diabetes (T2D). This initiative seeks to solicit applications that explore the use of FDA-cleared digital health technologies, such as continuous glucose monitoring, telemedicine, and mobile health applications, to enhance patient engagement, improve health outcomes, and address barriers to care in diabetes management. The opportunity is particularly significant as it aims to establish a rigorous evidence-based foundation for multimodal digital health interventions, which are currently lacking. Interested applicants, particularly from private institutions of higher education, are encouraged to begin forming collaborations and developing responsive projects, with the estimated synopsis post date set for September 12, 2025, and the application submission period expected to close on October 13, 2025. For further inquiries, potential applicants can contact Dr. Henry B. Burch at henry.burch@nih.gov or by phone at 301-827-0827.
    Clinical Validation of a Candidate Biomarker for Neurological or Neuromuscular Disorders (U44 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity for the clinical validation of candidate biomarkers for neurological and neuromuscular disorders through the U44 Cooperative Agreement mechanism. This initiative aims to rigorously validate biomarkers that have already been identified and for which detection methods have been developed, ensuring compliance with FDA guidelines to establish their clinical sensitivity and specificity. This program is crucial for advancing therapeutic development in the field of brain health, with funding potentially reaching $700,000 for Phase I and $1.5 million for Phase II projects. Interested applicants must adhere to specific submission guidelines and deadlines, with the application closing on June 22, 2026. For further information, applicants can contact NIH Grants Information at grantsinfo@nih.gov or visit the opportunity's webpage at https://grants.nih.gov/grants/guide/pa-files/PAR-24-096.html.
    Notice of Intent to Publish a Funding Opportunity Announcement: Technology Development to Reduce Health Disparities (R01 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is preparing to publish a Notice of Funding Opportunity (NOFO) aimed at soliciting applications for research focused on developing biomedical technologies that address health disparities. This initiative seeks to support projects that create effective, affordable, and socially acceptable technologies to improve healthcare access and outcomes for underserved populations. The estimated total program funding for this opportunity is $1,200,000, with an expected two awards to be made, and the application process is anticipated to open in late 2025. Interested applicants can reach out to Nichole Daringer at nichole.daringer@nih.gov or call 301-451-4774 for further information.
    Focused Technology Research and Development (R01 Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a Notice of Funding Opportunity (NOFO) for the Focused Technology Research and Development (R01 Clinical Trial Not Allowed) grant, aimed at supporting innovative technology projects that advance biomedical research. Eligible applicants include a diverse range of institutions, such as Historically Black Colleges and Universities, Tribal Colleges, and various community-based organizations, with a focus on projects that demonstrate proof-of-concept and the development of working prototypes without integrating clinical trials. This initiative is crucial for fostering technological advancements that enhance understanding of biological processes, with no budget cap and a maximum project duration of five years. Interested applicants can find more information and application guidelines at NIH Grants, with proposals due by January 7, 2028.
    Clinical Validation of a Candidate Biomarker for Neurological or Neuromuscular Disorders (U01 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Clinical Validation of a Candidate Biomarker for Neurological or Neuromuscular Disorders (U01 Clinical Trial Optional)." This initiative aims to support the clinical validation of strong candidate biomarkers for neurological and neuromuscular disorders, focusing on establishing their clinical sensitivity and specificity in accordance with FDA guidelines. The program is particularly significant as it seeks to enhance public health outcomes by facilitating the implementation of validated biomarkers in clinical settings, thereby addressing critical healthcare needs in these areas. Interested applicants should note that the application period opens on January 21, 2025, and closes on June 22, 2026. For further inquiries, applicants can contact NIH Grants Information at grantsinfo@nih.gov, and additional details can be found at the provided link: https://grants.nih.gov/grants/guide/pa-files/PAR-25-055.html.